EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TMEM16F phospholipid scramblase regulates tumorigenesis by modulating the tumor immune microenvironment

Menghan Wu, Peishang Shi, Jianmin Huang iD, Xiaomin Ni, Ruijia Lai iD, Kun Cao iD, Mengya Cai, Hao Yu iD, Wenshan Zhao iD, Yang Zhang iD

Proceedings of the National Academy of Sciences · 21.10.2025 · 122 (42)

DOI: 10.1073/pnas.2513910122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 16.10.2025. Verfasst von Menghan Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Physiology, Shenzhen Bay Laboratory, Shenzhen 518107, Guangdong, China. Hauptthemen laut MEDLINE: Phospholipid Transfer Proteins, Tumor Microenvironment, Anoctamins, Carcinogenesis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The National Natural Science Foundation of China, The Major Program of Shenzhen Bay Laboratory, Guangdong Pearl River Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immunosuppressive tumor microenvironment enables immune evasion through mechanisms beyond canonical immune checkpoints. While phosphatidylserine (PS) externalization coordinates apoptotic clearance under physiological conditions, tumors hijack this mechanism through apoptotic mimicry to subvert antitumor immunity. Here, we identify TMEM16F, a calcium-activated phospholipid scramblase, as a driver of tumor-intrinsic PS externalization. TMEM16F-mediated PS scrambling polarized macrophages to an immunosuppressive M2 phenotype, which promotes TGF-β1 secretion and regulatory T cell expansion to suppress cytotoxic lymphocytes. Genetic ablation of TMEM16F abolished PS exposure, systemically reprogrammed the tumor microenvironment and primary immune organs toward immune activation, and suppressed tumor growth across cancer models. Pharmacological scramblase inhibition produced these effects, demonstrating therapeutic potential. Our findings establish TMEM16F-dependent phospholipid scrambling as a critical immune evasion axis and propose targeting this pathway for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phospholipid Transfer ProteinsTumor MicroenvironmentAnoctaminsCarcinogenesisNeoplasmsAnimalsMicePhosphatidylserinesHumansMacrophagesMice, Inbred C57BLCell Line, TumorT-Lymphocytes, RegulatoryTransforming Growth Factor beta1

Stichwörter der Autor:innen

TMEM16Fphosphatidylserine exposurephospholipid scramblasetumor immune microenvironment

Substanzen

Phospholipid Transfer ProteinsAnoctaminsPhosphatidylserinesANO6 protein, mouseTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Institute of Molecular Physiology, Shenzhen Bay Laboratory, Shenzhen 518107, Guangdong, China.
  • School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
  • Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
  • The Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, Shenzhen 518055, China.
  • Department of Biomedical Engineering, Shenzhen University of Advanced Technology, Shenzhen 518118, China.
  • School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.

ORCID-Profile: Jianmin Huang, Ruijia Lai, Kun Cao, Hao Yu, Wenshan Zhao, Yang Zhang

Förderung

  • The National Natural Science Foundation of China
  • The Major Program of Shenzhen Bay Laboratory
  • Guangdong Pearl River Program
  • Natural Science Foundation of Henan Province
  • Shenzhen Fundamental Research Program
  • Science and Technology special fund of Hainan Province

Zitieren

APA

Wu, M., Shi, P., Huang, J., Ni, X., Lai, R., Cao, K., Cai, M., Yu, H., Zhao, W., & Zhang, Y. (2025). TMEM16F phospholipid scramblase regulates tumorigenesis by modulating the tumor immune microenvironment. Proceedings of the National Academy of Sciences, 122(42). https://doi.org/10.1073/pnas.2513910122

Vancouver

Wu M, Shi P, Huang J, Ni X, Lai R, Cao K, et al. TMEM16F phospholipid scramblase regulates tumorigenesis by modulating the tumor immune microenvironment. Proceedings of the National Academy of Sciences. 2025;122(42). doi:10.1073/pnas.2513910122

BibTeX
@article{Wu2025,
  author = {Wu, Menghan and Shi, Peishang and Huang, Jianmin and Ni, Xiaomin and Lai, Ruijia and Cao, Kun and Cai, Mengya and Yu, Hao and Zhao, Wenshan and Zhang, Yang},
  title = {TMEM16F phospholipid scramblase regulates tumorigenesis by modulating the tumor immune microenvironment},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {42},
  doi = {10.1073/pnas.2513910122}
}
Kostenlos starten →